Stephanie A. Terezakis MD, Moderator: Nothing to Disclose

1) To understand the role of computed tomography and positron emission tomography-CT in the management of patients with Hodgkin and non-Hodgkin lymphoma. 2) To become familiar with the International Working Group Criteria, which integrate PET findings into lymphoma response assessment. 3) To become familiar with limitations of PET-CT in assessing lymphoma response by PET-CT. 4) To become aware of pitfalls (false positives) of PET-CT in the response assessment of patients with lymphoma.

Although computed tomography remains the gold standard for assessment of lymphoma response to therapy, PET-CT plays an important role for both staging and response evaluation. In this session we will review the role of imaging in lymphoma and demonstrate how it guides therapy in this patient population. The limitations of PET imaging as well as pitfalls and false positives of PET imaging will be addressed.

Terezakis, S, New Paradigms for the Treatment of Hodgkin's and non-Hodgkin's Lymphomas: The Crucial Role of Imaging.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/12020990.html